IMMUNOTHERAPY. Outsourcing the immune response to cancer
- PMID: 27284181
- DOI: 10.1126/science.aag1547
IMMUNOTHERAPY. Outsourcing the immune response to cancer
Comment on
-
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.Science. 2016 Jun 10;352(6291):1337-41. doi: 10.1126/science.aaf2288. Epub 2016 May 19. Science. 2016. PMID: 27198675
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical